Vor Biopharma VOR
NASDAQ VOR
$20.09 +0.53 (+2.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Vor Biopharma (VOR) Other Non-Current Liabilities (2025 - 2026)

Updated

Vor Biopharma (VOR) posted Other Liabilities of $594.7 million for Q3 2026, down 75.0% from $2.38 billion a year earlier and down 9.1% from the prior quarter.

Analysis

Vor Biopharma (VOR) Other Non-Current Liabilities (2025 - 2026) Analysis & Trends

At the end of FY2025, Vor Biopharma's Other Liabilities came in at $600.55 million.

  • According to Business Quant data, Other Liabilities for the three prior quarters was $653.89 million (Q2 2026), $638.46 million (Q1 2026) and $600.55 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Vor Biopharma 1.20 Bn -692.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 594.70 Mn
Jun 30, 2026 653.89 Mn
Mar 31, 2026 638.46 Mn
Dec 31, 2025 600.55 Mn
Sep 30, 2025 2.38 Bn
Jun 30, 2025 1.65 Bn
API Access

Vor Biopharma Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=VOR&period=max&api_key=YOUR_API_KEY